Prescriber's Corner

Elotuzumab: The First Monoclonal Antibody for the Treatment of Multiple Myeloma

Karen M. Fancher,(1,2) PharmD, BCOP, and Elizabeth J. Bunk,(1) PharmD

¹Duquesne University Mylan School of Pharmacy, Pittsburgh, Pennsylvania; ²University of Pittsburgh Medical Center Passavant, Pittsburgh, Pennsylvania

Authors’ disclosures of potential conflict of interest are found at the end of this article.

Karen M. Fancher, PharmD, BCOP, Duquesne University Mylan School of Pharmacy, 322 Bayer Building, 600 Forbes Avenue, Pittsburgh, PA 15232. E-mail: fancherk@duq.edu


J Adv Pract Oncol 2016;7:542–547 | doi: 10.6004/jadpro.2016.7.5.6 | © 2016 Harborside Press®


  



For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.